Clinical trial
A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid
NCT04315415 is registered in ClinicalTrials.gov with Sofregen Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid
- Lead sponsor
- Sofregen Medical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 15, 2020
- Completion date
- April 18, 2022
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vocal cord atrophy, vocal cord paralysis, vocal fold palsy